4.5 Article

Synthesis and in vivo antimalarial activity of novel naphthoquine derivatives with linear/cyclic structured pendants

Journal

FUTURE MEDICINAL CHEMISTRY
Volume 9, Issue 11, Pages 1117-1127

Publisher

FUTURE SCI LTD
DOI: 10.4155/fmc-2017-0058

Keywords

antimalarial; in vivo activity; naphthoquine; synthesis

Funding

  1. National S&T Major Special Project on Major New Drug Innovations [2015ZX09102022]
  2. NSFC [81502923]

Ask authors/readers for more resources

Aim: Naphthoquine (NQ) was discovered by our institute as an antimalarial candidate in 1980s, and currently employed as an artemisinin-based combination therapy partner drug. Resistance to NQ was found in mouse model in laboratory, and might emerge in future as widely used. Methodology: We herein report the design and synthesis of NQ derivatives by replacing t-butyl moiety with linear/cyclic structured pendants. All the target compounds 6a-l and intermediates 5a-h were tested for their in vivo antimalarial activity against Plasmodium berghei K173 strain in mice. Results: Compounds 6a and 6j were found to have a comparable or slightly more potent activity (the 50% effective dose [ED50], which is required to decrease parasitemia by 50%: 0.38-0.43 mg/kg) than NQ (ED50 : 0.48 mg/kg). Conclusion: The newly designed compounds 6a and 6j might be promising antimalarial candidates for further research.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Chemistry, Multidisciplinary

N-(2-Phenoxy)ethyl imidazo[1,2-a]pyridine-3-carboxamides containing various amine moieties: Design, synthesis and antitubercular activity

Linhu Li, Apeng Wang, Bin Wang, Mingliang Liu, Kai Lv, Zeyu Tao, Chao Ma, Xican Ma, Bing Han, Aoyu Wang, Yu Lu

CHINESE CHEMICAL LETTERS (2020)

Article Biochemistry & Molecular Biology

Design, synthesis and anti-HBV activity of NVR3-778 derivatives

Kai Lv, Shuo Wu, Wenyan Li, Yunhe Geng, Meng Wu, Jinming Zhou, Yuhuan Li, Qiang Gao, Mingliang Liu

BIOORGANIC CHEMISTRY (2020)

Article Chemistry, Medicinal

Amino acid prodrugs of NVR3-778: Design, synthesis and anti-HBV activity

Kai Lv, Wenyan Li, Shuo Wu, Yunhe Geng, Apeng Wang, Lu Yang, Menghao Huang, Kushan Chowdhury, Yuhuan Li, Mingliang Liu

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2020)

Article Chemistry, Medicinal

Identification of benzothiazinones containing 2-benzyl-2,7-diazaspiro [3.5]nonane moieties as new antitubercular agents

Apeng Wang, Chao Ma, Yun Chai, Xiujun Liu, Kai Lv, Lei Fu, Bin Wang, Xuedong Jia, Mingliang Liu, Yu Lu

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)

Article Biochemistry & Molecular Biology

Design, synthesis and antimycobacterial activity of new benzothiazinones inspired by rifampicin/rifapentine

Apeng Wang, Yu Lu, Kai Lv, Chao Ma, Shijie Xu, Bin Wang, Aoyu Wang, Guimin Xia, Mingliang Liu

BIOORGANIC CHEMISTRY (2020)

Article Chemistry, Medicinal

Design, synthesis and biological activity of N-(amino)piperazine-containing benzothiazinones against Mycobacterium tuberculosis

Apeng Wang, Shijie Xu, Yun Chai, Guimin Xia, Bin Wang, Kai Lv, Chao Ma, Dan Wang, Aoyu Wang, Xiaoyu Qin, Mingliang Liu, Yu Lu

Summary: A series of novel benzothiazinone derivatives containing a N-(amino)piperazine moiety, based on the structure of WAP-1902 discovered in the lab, were designed and synthesized as new anti-TB agents. Many compounds showed excellent in vitro activity against drug-sensitive MTB strain H37Rv and multidrug-resistant clinical isolates, with good safety index. Compound 1o, in particular, displayed low hERG cardiac toxicity and acceptable oral pharmacokinetic profiles, indicating its potential as a lead compound for future antitubercular drug discovery.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)

Article Biochemistry & Molecular Biology

Design, synthesis and biological evaluation of nitrofuran-1,3,4-oxadiazole hybrids as new antitubercular agents

Apeng Wang, Shijie Xu, Yun Chai, Guimin Xia, Bin Wang, Kai Lv, Dan Wang, Xiaoyu Qin, Bin Jiang, Wenhao Wu, Mingliang Liu, Yu Lu

Summary: The structure-activity relationship study of novel nitrofuran-1,3,4-oxadiazole hybrids as anti-TB agents showed that linkers and substituents greatly influence the activity, with substituted benzenes being more favored. The optimal compound in series 2 demonstrated strong activity against both MTB strains and low toxicity, indicating its potential as a lead compound for further development.

BIOORGANIC & MEDICINAL CHEMISTRY (2022)

Article Chemistry, Medicinal

Optimization and SAR research at the piperazine and phenyl rings of JNJ4796 as new anti-influenza A virus agents, part 1

Aoyu Wang, Yuhuan Li, Kai Lv, Rongmei Gao, Apeng Wang, Haiyan Yan, Xiaoyu Qin, Shijie Xu, Chao Ma, Jiandong Jiang, Zengquan Wei, Kai Zhang, Mingliang Liu

Summary: JNJ4796, a small molecule fuse inhibitor, effectively neutralizes a broad spectrum of IAV and protects mice after oral administration. Compound (R)-2c shows excellent in vitro anti-IAV activity and low cytotoxicity, with a low inhibition rate of hERG.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)

Article Chemistry, Medicinal

Identification of (6S)-cyclopropyl-6,7-dihydropyrazolo[1,5-a]pyrazine-5(4H)-carboxamines as new HBV capsid assembly modulators

Kai Lv, Shuo Wu, Zeyu Tao, Aoyu Wang, Shijie Xu, Lu Yang, Qiang Gao, Apeng Wang, Xiaoyu Qin, Bin Jiang, Wenhao Wu, Xuedong Jia, Yuhuan Li, Jiandong Jiang, Mingliang Liu

Summary: GYH2-18, a type II HBV CAM, was discovered to have anti-HBV activity. Derivatives of GYH2-18 were synthesized and evaluated, and compounds 2f and 3k showed excellent anti-HBV activity and low cytotoxicity. Chiral separation of 2f and 3k was successful, and (6S)-cyclopropyl DPPC isomers were found to be more active than the corresponding (6R)-ones.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2022)

Article Chemistry, Medicinal

Identification of dihydroquinolizinone derivatives with cyclic ether moieties as new anti-HBV agents

Xiaoyu Qin, Lu Yang, Xican Ma, Bin Jiang, Shuo Wu, Apeng Wang, Shijie Xu, Wenhao Wu, Huijuan Song, Na Du, Kai Lv, Yuhuan Li, Mingliang Liu

Summary: RG7834, a DHQ candidate developed by Roche Pharma, was dismissed in phase I clinical trial due to its neurotoxicity. In this study, new DHQ derivatives containing a cyclic ether or benzo-fused ether moiety were designed, synthesized and evaluated for their in vitro activity. Many of them exhibited potent inhibition activity against HBV and showed potential improvement in neurotoxicity.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2022)

Article Chemistry, Medicinal

Optimization and SAR research at the benzoxazole and tetrazole rings of JNJ4796 as new anti-influenza A virus agents, part 2

Wenhao Wu, Haiyan Yan, Bin Jiang, Aoyu Wang, Xingqiong Li, Yuehao Zhang, Jizhou Wu, Xijun Zhong, Rongmei Gao, Apeng Wang, Kai Lv, Yuhuan Li, Mingliang Liu

Summary: This study describes the structure-activity relationship of the benzoxazole and tetrazole rings of JNJ4796. Many derivatives showed good in vitro activity against IAV H1N1 and Oseltamivir-resistant IAV H1N1 strains. Compound (R)-1a, identified in a previous study, displayed potent in vivo anti-IAV activity with survival rates comparable to JNJ4796.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2023)

Article Chemistry, Physical

Identification of 3-nitrophenol ester derivatives as novel quorum-sensing inhibitors of Pseudomonas aeruginosa

Bo Wang, Yang Yang, Weixiao Wang, Jiaoyang Yu, Fengwan Zhang, Shuo Wu, Shijie Xu, Na Du, Xiaoyu Qin, Huijuan Song, Wenhao Wu, Bin Jiang, Mingliang Liu, Apeng Wang, Kai Lv, Wei Chen

Summary: In this study, a series of 3-nitrophenol ester derivatives were identified as promising quorum-sensing inhibitors through Structure-based Virtual Screening and structural optimization. Among them, 3-nitrophenol ester 1b showed potent LasR inhibition activity and low cytotoxicity. Molecular docking study revealed the formation of three intermolecular hydrogen bonds between 1b and the residues. Moreover, 1b was found to significantly inhibit the virulence of P. aeruginosa in vitro and in vivo, and transcriptome analysis indicated the inhibition of QS-related genes.

JOURNAL OF MOLECULAR STRUCTURE (2023)

Article Chemistry, Medicinal

Design, synthesis and anti-TB and anti-bacterial activity of Ciprofloxacin derivatives containing N-(amino)piperazine moieties

Xiaoyu Qin, Bin Jiang, Huijuan Song, Na Du, Yuehao Zhang, Xijun Zhong, Jizhou Wu, Tiezheng Xue, Mingliang Liu, Apeng Wang, Sanlong Wang, Kai Lv

Summary: In this study, the combination of quinolones and rifamycins was investigated to explore their potential against bacterial infections. Different substituents were incorporated into the N-(amino)piperazine moieties to enhance the anti-TB and antibacterial potency. Compounds 1k and 3e showed comparable activity to the reference drug, while compound 1d exhibited significantly higher potency against MRSA and VRE E.fm. These findings suggest the potential of compounds 1d and 1k as new leads for antibacterial and anti-TB drug development.

MEDICINAL CHEMISTRY RESEARCH (2023)

Article Chemistry, Medicinal

Discovery and pharmacological characterization of a novel benzimidazole TRPV4 antagonist with cyanocyclobutyl moiety

Chongyi Ai, Zhuang Wang, Pengyun Li, Mengyuan Wang, Wenjuan Zhang, Huijuan Song, Xu Cai, Kai Lv, Xingjuan Chen, Zhibing Zheng

Summary: GSK-Bz, a TPRV4 antagonist discovered by GSK, showed potent TRPV4 inhibition activity and effectively inhibited TRPV4-mediated pulmonary edema in a rat model. In this study, a series of GSK-Bz derivatives were designed and synthesized. Compound 2b demonstrated superior potency compared to GSK-Bz, with enhanced inhibitory effects on TRPV4 currents and LPS permeability response. Additionally, 2b outperformed HC-067047 in protecting against acute lung injury in a mice model. These findings highlight the potential of 2b as a novel and highly potent TRPV4 antagonist for further development. Evaluation of the drug-like properties of 2b is currently underway.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2023)

Article Chemistry, Multidisciplinary

Identification of benzothiazones containing a hexahydropyrrolo[3,4-c]pyrrol moiety as antitubercular agents against MDR-MTB

Xican Ma, Bing Han, Aoyu Wang, Lu Yang, Menghao Huang, Kushan Chowdhury, Jian Gu, Kai Zhang, Kai Lv

RSC ADVANCES (2020)

No Data Available